DE3588043D1 - Cytokeratin-tumormarkierer und test zu deren nachweis. - Google Patents
Cytokeratin-tumormarkierer und test zu deren nachweis.Info
- Publication number
- DE3588043D1 DE3588043D1 DE3588043T DE3588043T DE3588043D1 DE 3588043 D1 DE3588043 D1 DE 3588043D1 DE 3588043 T DE3588043 T DE 3588043T DE 3588043 T DE3588043 T DE 3588043T DE 3588043 D1 DE3588043 D1 DE 3588043D1
- Authority
- DE
- Germany
- Prior art keywords
- detect
- test
- neoplastic
- tumor marker
- cytokeratin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3015—Breast
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4742—Keratin; Cytokeratin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56886284A | 1984-01-06 | 1984-01-06 | |
PCT/US1985/000010 WO1985003132A1 (en) | 1984-01-06 | 1985-01-03 | Cytokeratin tumor markers and assays for their detection |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3588043D1 true DE3588043D1 (de) | 1995-08-31 |
DE3588043T2 DE3588043T2 (de) | 1996-03-21 |
Family
ID=24273031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3588043T Expired - Lifetime DE3588043T2 (de) | 1984-01-06 | 1985-01-03 | Cytokeratin-tumormarkierer und test zu deren nachweis. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4775620A (de) |
EP (1) | EP0167616B1 (de) |
JP (5) | JP2723203B2 (de) |
AT (1) | ATE125626T1 (de) |
CA (1) | CA1336171C (de) |
DE (1) | DE3588043T2 (de) |
WO (1) | WO1985003132A1 (de) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR850552B (de) * | 1984-03-07 | 1985-07-05 | Du Pont | |
ATE86261T1 (de) * | 1986-04-17 | 1993-03-15 | Hybritech Inc | Tumorassoziiertes antigen. |
DE3786695T2 (de) * | 1986-04-17 | 1993-12-16 | Hybritech Inc | Tumorassoziiertes Antigen. |
FR2606033B1 (fr) * | 1986-10-31 | 1988-12-16 | Cird | Proteine cytoplasmique des cellules suprabasales de l'epiderme, anticorps capables de reconnaitre cette proteine, et lignees cellulaires hybrides capables de secreter de tels anticorps |
FR2606034B1 (fr) * | 1986-10-31 | 1989-06-02 | Cird | Nouvelle proteine de surface des cellules basales de l'epiderme, anticorps capables de reconnaitre cette proteine, et leur utilisation, et lignees cellulaires hybrides capables de secreter de tels anticorps |
DE3815932A1 (de) * | 1988-01-26 | 1989-08-03 | Progen Biotechnik Gmbh | Verfahren zur identifizierung des ursprungs einer zellgewebsprobe |
US5660994A (en) * | 1986-11-10 | 1997-08-26 | Progen Biotechnik Gmbh | Method of detecting tissue-specific, insoluble cytoskeletal proteins |
DE3923951A1 (de) * | 1989-07-19 | 1991-01-31 | Boehringer Mannheim Gmbh | Verfahren zum nachweis von leberzirrhose |
US5411868A (en) * | 1989-10-24 | 1995-05-02 | Board Of Regents, The University Of Texas System | Diagnostic and premonitoring uses of a 65 kDa tumor-associated protein in companion and domestic animal malignancy |
DE3942999C2 (de) * | 1989-12-27 | 1997-12-18 | Progen Biotechnik Gmbh | Verfahren zum Nachweis von malignen Erkrankungen |
DE4023945A1 (de) * | 1990-07-27 | 1992-01-30 | Progen Biotechnik Gmbh | Verfahren zur reinigung von cytokeratin 20 und dessen verwendung zur erzeugung von antikoerpern |
SE470273B (sv) * | 1990-09-24 | 1993-12-20 | Idl Immunodeveloplab Ab | Cytokeratinfragment, deras framställning och användning, framställning av monoklonala antikroppar och testkit för epitelialcancer |
US5547928A (en) * | 1993-12-17 | 1996-08-20 | Matritech, Inc. | Methods and compositions for the detection of colon cancers |
SE9500023L (sv) * | 1994-05-17 | 1995-11-18 | Beki Ab | Sätt att detektera cancer |
US5914238A (en) * | 1996-06-05 | 1999-06-22 | Matritech, Inc. | Materials and methods for detection of breast cancer |
US5858683A (en) | 1996-08-30 | 1999-01-12 | Matritech, Inc. | Methods and compositions for the detection of cervical cancer |
US6168779B1 (en) * | 1997-09-16 | 2001-01-02 | The Regents Of The University Of California | Methods and kits for identifying ductal orifices |
US6890311B2 (en) | 1997-09-16 | 2005-05-10 | The Regents Of The University Of California | Methods for performing medical procedures within a breast duct |
JP2002503814A (ja) | 1998-02-12 | 2002-02-05 | イムニベスト・コーポレイション | 循環ガン細胞の迅速かつ効率的な単離のための方法および試薬 |
GB9905817D0 (en) * | 1999-03-12 | 1999-05-05 | Oxford Glycosciences Uk Ltd | Methods |
ATE403154T1 (de) * | 1999-04-13 | 2008-08-15 | Wilex Ag | Diagnostischer und therapeutischer einsatz von antikörpern gegen den urokinase-rezeptor |
EP1208381A2 (de) * | 1999-08-13 | 2002-05-29 | Oxford GlycoSciences (UK) Limited | Verfahren zum nachweis von brustkrebs |
AU2596901A (en) * | 1999-12-21 | 2001-07-03 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
GB0004576D0 (en) * | 2000-02-25 | 2000-04-19 | Oxford Glycosciences Uk Ltd | Proteins |
DE10130985B4 (de) * | 2001-06-27 | 2004-03-18 | B.R.A.H.M.S Ag | Verfahren zur Diagnose von Sepsis und schweren Infektionen unter Bestimmung löslicher Cytokeratin-1-Fragmente |
JP4302518B2 (ja) | 2001-08-31 | 2009-07-29 | ケラテク リミテッド | 可溶性s−スルホン化ケラチン誘導体からの生体高分子材料の薄膜、繊維、発泡体又は接着剤の製造 |
WO2003024191A2 (en) * | 2001-09-21 | 2003-03-27 | Raven Biotechnologies, Inc. | Antibodies that bind to cancer-associated antigen cytokeratin 8 and methods of use thereof |
US7630403B2 (en) * | 2002-03-08 | 2009-12-08 | Texas Instruments Incorporated | MAC aggregation frame with MSDU and fragment of MSDU |
NZ550755A (en) * | 2002-06-10 | 2009-06-26 | Keratec Ltd | Orthopaedic materials derived from keratin |
EP1572132A4 (de) * | 2002-11-28 | 2008-10-08 | Keratec Ltd | Keratinhaltige körperpflegeformulationen |
US7767756B2 (en) * | 2003-09-19 | 2010-08-03 | Keraplast Technologies, Ltd. | Composite materials containing keratin |
WO2005043166A1 (ja) * | 2003-10-30 | 2005-05-12 | Sysmex Corporation | 子宮腺癌の診断薬及び腺癌細胞の検出方法 |
AU2004298392A1 (en) * | 2003-12-19 | 2005-06-30 | Keratec Limited | Wound care products containing keratin |
US7579317B2 (en) * | 2005-03-11 | 2009-08-25 | Keratec, Ltd. | Nutraceutical composition comprising soluble keratin or derivative thereof |
ES2375453T3 (es) * | 2006-09-07 | 2012-03-01 | Universitätsklinikum Hamburg-Eppendorf | Método para la detección de células epiteliales cancerosas utilizando citoqueratinas liberadas como marcadores para dichas células. |
CA2672069A1 (en) * | 2006-12-06 | 2008-06-12 | Keratec, Ltd. | Bone void fillers and methods of making the same |
CA2672529A1 (en) * | 2006-12-11 | 2008-06-19 | Keratec, Ltd. | Porous keratin construct and method of making the same |
US20080317826A1 (en) * | 2007-05-24 | 2008-12-25 | Robert James Kelly | Porous keratin constructs, wound healing assemblies and methods using the same |
EP2215105A4 (de) * | 2007-10-31 | 2011-06-22 | Keraplast Tech Ltd | Keratinderivate und verfahren zu deren herstellung |
US11090394B1 (en) | 2012-03-27 | 2021-08-17 | Florida A&M University | Modified nanodelivery system and method for enhanced in vivo medical and preclinical imaging |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4150149A (en) * | 1976-11-29 | 1979-04-17 | Professional Staff Association Of The Los Angeles County Harbor General Hospital | Method and means for the early detection and diagnosis of certain types of cancers |
US4229426A (en) * | 1978-02-22 | 1980-10-21 | Duke University, Inc. | Breast cyst fluid protein assay |
US4331647A (en) * | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
CA1190853A (en) * | 1981-10-13 | 1985-07-23 | Roberto L. Ceriani | Method and compositions for carcinoma diagnosis |
CA1215331A (en) * | 1983-03-04 | 1986-12-16 | Tsann M. Chu | Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy |
-
1985
- 1985-01-03 AT AT85900840T patent/ATE125626T1/de not_active IP Right Cessation
- 1985-01-03 DE DE3588043T patent/DE3588043T2/de not_active Expired - Lifetime
- 1985-01-03 JP JP60500313A patent/JP2723203B2/ja not_active Expired - Lifetime
- 1985-01-03 EP EP85900840A patent/EP0167616B1/de not_active Expired - Lifetime
- 1985-01-03 WO PCT/US1985/000010 patent/WO1985003132A1/en active IP Right Grant
- 1985-01-07 CA CA000471619A patent/CA1336171C/en not_active Expired - Lifetime
- 1985-01-30 US US06/696,284 patent/US4775620A/en not_active Expired - Lifetime
-
1988
- 1988-07-18 JP JP63177251A patent/JPH0681760B2/ja not_active Expired - Lifetime
- 1988-07-18 JP JP63177250A patent/JP2537539B2/ja not_active Expired - Lifetime
-
1996
- 1996-04-09 JP JP8086581A patent/JP2617289B2/ja not_active Expired - Lifetime
-
1997
- 1997-09-25 JP JP9260504A patent/JP2896362B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH0681760B2 (ja) | 1994-10-19 |
CA1336171C (en) | 1995-07-04 |
WO1985003132A1 (en) | 1985-07-18 |
EP0167616A4 (de) | 1986-09-04 |
JP2723203B2 (ja) | 1998-03-09 |
EP0167616A1 (de) | 1986-01-15 |
EP0167616B1 (de) | 1995-07-26 |
JP2537539B2 (ja) | 1996-09-25 |
JP2896362B2 (ja) | 1999-05-31 |
JPS6452800A (en) | 1989-02-28 |
JPS6447392A (en) | 1989-02-21 |
JPH08275778A (ja) | 1996-10-22 |
JP2617289B2 (ja) | 1997-06-04 |
US4775620A (en) | 1988-10-04 |
JPH10123138A (ja) | 1998-05-15 |
JPS61501048A (ja) | 1986-05-22 |
DE3588043T2 (de) | 1996-03-21 |
ATE125626T1 (de) | 1995-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3588043T2 (de) | Cytokeratin-tumormarkierer und test zu deren nachweis. | |
BR0112542A (pt) | Composições e métodos papa a terapia e a diagnose de câncer ovariano | |
BR9916207A (pt) | Composições e métodos para terapia e diagnósticode câncer ovariano | |
BR0009537A (pt) | Composições para tratamento e diagnóstico de câncer de mama e métodos para seu uso | |
SE7906148L (sv) | Forfarande for framstellning av en biologisk komposition for anvendning sasom referenskontroll vid diagnostiska tester | |
DE3586440D1 (de) | Zur diagnose von menschlichem magen- oder brustkrebs zu verwendender monoklonaler antikoerper. | |
BR9808509A (pt) | Composições e métodos para o tratamento e diagnóstico do câncer de mama | |
NO830570L (no) | Antistoffer og antigener for diagnose og behandling av cancer | |
BR0009608A (pt) | Compostos para imunoterapia e diagnóstico de câncer de mama e métodos para sua utilização | |
DK0454782T3 (da) | Cancer-beslægtet haptaglobin (Hpr.) | |
ATE71225T1 (de) | Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnoseoder therapieverfahren bezueglich krebskrankheiten. | |
ATE514780T1 (de) | Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon | |
Tosca et al. | Antigenic alterations in tumors of epidermal origin | |
ES520418A0 (es) | Procedimiento para la formacion de suelas con tacon y tapa final del tacon,para calzados,generalmente femeninos,con nucleo o armadura de sostenimiento incorporado | |
ATE475710T1 (de) | Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs | |
NO173336C (no) | Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein | |
DK359685A (da) | Fremgangsmaade til paavisning af malign formering | |
DE3070210D1 (en) | A process for preparing tumor antidotes (oncoclasines) from the excrements of goats | |
IT7830722A0 (it) | Metodo di prova in vitro per la diagnosi di tumori maligni. | |
SU1077090A1 (ru) | Способ получени вещества,специфически св зывающего раково-эмбриональный антиген опухолей толстого кишечника человека | |
IT8367899A0 (it) | Composizione per la cura dei tumori maligni in particolare sugli animali | |
Canagaratnam | Urinary hydroxyproline in malignancies involving bone | |
SADAHIRO et al. | A CLINICOPATHOLOGICAL STUDY OF CASES WITH CANCER OF UNKNOWN ORIGIN ANALYSIS OF CELLULAR PROTEINS IN PRIMARY AND METASTATIC CANCEROUS TISSUE | |
Merkle et al. | Tumor cell detection in bone marrow of primary breast cancer patients | |
JPH11511847A (ja) | 癌の検出及び処理 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8365 | Fully valid after opposition proceedings |